Source: Pharmacy Times articles
Elranatamab is a B-cell maturation antigen (BCMA)-CD3-targeted bispecific antibody.
Read More
by | Nov 4, 2022 | Myeloma News | 0 comments
Source: Pharmacy Times articles
Elranatamab is a B-cell maturation antigen (BCMA)-CD3-targeted bispecific antibody.
Read More